Skeletal Muscle Protein Synthesis: Traditional and Cluster Sets
1 other identifier
interventional
8
1 country
1
Brief Summary
Traditionally, when performing resistance exercise, repetitions are performed in a continuous manner resulting in a decrease in velocity, and thus power output. "Cluster" set is an alternative to counter the reduction in velocity and power output. Cluster sets incorporate a brief rest (15-30 seconds) between individual repetitions (inter-repetition rest) or group of repetitions (intra-set rest) within a set of resistive exercise. In contrast to traditional set configurations, which result in an almost linear decrease in force, velocity, and power -cluster sets maintain and/or attenuate the loss in power, primarily due to higher velocities. The purpose of this research is to compare the muscle protein synthesis response to acute bouts of cluster and traditional set configurations. Investigators will assess muscle protein synthesis rates before and after acute resistance exercise in 14 resistance-trained males and females (Age: 20-35; back squat 1.5 x body weight; 3 years of resistance training experience). The volunteers are required to be removed (at least six weeks) from all ergogenic levels of nutritional supplements that have previously been shown to affect protein synthesis. Blood and muscle biopsies will be collected as a part of testing. Further, subjects will be required to perform moderate-to-high intensity resistance exercise.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 2, 2018
CompletedStudy Start
First participant enrolled
August 25, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 25, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
July 15, 2019
CompletedFirst Posted
Study publicly available on registry
July 23, 2019
CompletedJuly 24, 2019
July 1, 2019
2 months
August 2, 2018
July 22, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Fractional Synthetic Rate of Myofibrillar Proteins
Myofibrillar muscle protein synthesis rates will be assessed during the 2hr Postabsorptive period (e.g. non-fed state) and the 5hr postprandial period (e.g. fed state) for both experimental interventions (e.g. leucine and leucine peptide). This will allow us to assess the change in fractional synthetic rate from the Postabsorptive period to the postprandial period.
Postabsorptive for 2 hours, Postprandial for 5 hours
Study Arms (2)
Cluster set Resistance Training Protocol
ACTIVE COMPARATORCluster set configuration is the new training approach that it is being tested.
Traditional Resistance Training Protocol
SHAM COMPARATORTraditional is commonly used in training sessions.
Interventions
Participants begin with a 5 min dynamic warm-up. Then, they will perform two sets of five repetitions at 40-60% of predetermined 1-repetition maximum (1-RM). The clustered bout will be 4 sets of 2 clusters of 5 repetitions with a 30-second intra-set rest between clusters, and 90-second inter-set rest at a load 70% of 1-RM. The traditional bout will be 4 sets of 10 repetitions with a 120-second inter-set rest at a load 70% of 1-RM.
Eligibility Criteria
You may qualify if:
- Resistance-trained adults
- Back squat 1.5x body weight
- years resistance-training experience
- Aged between 20-35 years
You may not qualify if:
- Tobacco use (previous 6 months)
- Alcohol consumption \>10 drinks per week
- Metabolic disorders, diabetes, thyroid disease, hypogonadism
- Heart disease, arrhythmias, asthma
- History of uncontrolled hypertension
- Orthopaedic injury/surgery within the last year
- Hepatorenal, musculoskeletal, autoimmune, neuromuscular, or neurologic disease
- Consumed ergogenic levels of nutritional supplements that may affect muscle mass (i.e. creatine, HMB), insulin-like substances, or anabolic/catabolic pro-hormones (i.e. DHEA) within six weeks prior to the onset of the study
- Individuals consuming thyroid, androgenic, or other medications known to affect endocrine function
- Individuals on any medications known to affect protein metabolism (i.e. corticosteroids, non-steroidal anti- inflammatories, or prescription strength acne medications)
- Pregnant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Freer Hall
Urbana, Illinois, 61801, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Nicholas Burd, PhD
University of Illinois at Urbana-Champaign
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
August 2, 2018
First Posted
July 23, 2019
Study Start
August 25, 2018
Primary Completion
October 25, 2018
Study Completion
July 15, 2019
Last Updated
July 24, 2019
Record last verified: 2019-07
Data Sharing
- IPD Sharing
- Will not share